Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Growth hormone-releasing hormone (GHRH) boosts hair growth and human scalp hair follicles have their own growth hormone system.

Skin produces different hormones depending on body part and sex, and a new method can measure them.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Thyroid hormone levels in children are linked to growth hormone and can be affected by diabetes in Riyadh, Saudi Arabia.

A woman with childhood growth hormone deficiency had multiple hormone deficiencies and developed serious lung and kidney problems later in life.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Different hair loss patterns may be linked to varying male hormone levels.

People with hair loss have different hormone levels, and these hormones can affect hair growth.

People with early onset baldness (AGA) have higher blood sugar levels and lower sex hormone-binding globulin (SHBG) levels, suggesting SHBG could predict high blood sugar in these individuals.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

TRH stimulates human hair growth and extends the hair growth phase.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.